NCT07195227
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07195227
Title Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer (CADILLAC)
Acronym CADILLAC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | DEU

Facility Status City State Zip Country Details
Städtisches Klinikum Dessau ACTIVE_NOT_RECRUITING Dessau Germany Details
Hospital General Universitario Dr. Balmis ACTIVE_NOT_RECRUITING Alicante Spain Details
Hospital Clínic Barcelona RECRUITING Barcelona Spain Details
Hospital Dexeus RECRUITING Barcelona Spain Details
Institut Català d'Oncologia Girona - ICO Girona RECRUITING Girona Spain Details
HU Virgen de las Nieves ACTIVE_NOT_RECRUITING Granada Spain Details
Hospital Universitario de Jerez de la Frontera RECRUITING Jerez de la Frontera Spain Details
Hospital Universitario de León RECRUITING León Spain Details
Beata Maria Ana ACTIVE_NOT_RECRUITING Madrid Spain Details
Hospital Ramón y Cajal ACTIVE_NOT_RECRUITING Madrid Spain Details
Hospital Regional Universitario de Málaga ACTIVE_NOT_RECRUITING Málaga Spain Details
Sant Joan de Reus RECRUITING Reus Spain Details
H Quirónsalud Sagrado Corazón ACTIVE_NOT_RECRUITING Seville Spain Details
Hospital Universitario y Politécnico de La Fe ACTIVE_NOT_RECRUITING Valencia Spain Details
HUAV Valencia RECRUITING Valencia Spain Details
IVO - Instituto Valenciano de Oncología RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field